Articles Tagged With:
-
Management of Problem Wounds in the Emergency Department
Most acute wounds will heal with good topical care. However, some wounds, especially chronic ones occurring in impaired hosts, are more problematic. To properly manage these types of wounds and optimize healing, there should be an evidence-based approach to wound care in the emergency department.
-
Infectious Disease Alert Updates
Excess Deaths During COVID-19; Subclinical Influenza Infection in Healthcare Workers; Compression Garments Effective in Reducing Cellulitis
-
CMS Updates COVID-19 Infection Control Survey
The Centers for Medicare & Medicaid Services revised its “COVID-19 Focused Infection Control Survey Tool: Acute and Continuing Care” recently.
-
Neurotropism of COVID-19: What Is New?
SARS-CoV-2 may gain access to the brain via the olfactory epithelium. The olfactory epithelium and bulbs may serve as an entry point for SARS-CoV-2 infection into the central nervous system.
-
Does the Addition of IV Metronidazole Improve Outcomes of Severe Clostridioides difficile Infection?
These studies indicate that the addition of intravenously administered metronidazole in the treatment of severe Clostridioides difficile infection is unwarranted.
-
With Focus on COVID-19, Other HAIs Increase
Infection preventionists are reporting increasing outbreaks of healthcare associated infections as the COVID-19 pandemic demands outsized efforts by overworked caregivers.
-
Malaria and Anemia — Chemoprophylaxis Helps
For young children in Africa who return home after hospitalization for severe anemia, monthly long-acting malaria prophylaxis can reduce the rates of readmission and death during the three months following hospitalization.
-
Candidemia in the United States
Candidemia, a common bloodstream infection in the United States, is associated with high mortality. There is concern about increasing resistance to antifungals.
-
COVID-19 Shots Causing Anaphylactic Shock at 10 Times Rate of Other Vaccines
With millions more healthcare workers and the general public slated to be immunized for COVID-19, researchers report that the Pfizer SARS-CoV-2 mRNA vaccine is causing anaphylactic shock reactions at 10 times the rate of typical vaccines.
-
Healthcare Workers with Antibody to SARS-CoV-2 Have Strong Protection Against Reinfection
A study of healthcare workers demonstrated that the presence of antibody to SARS-CoV-2 spike protein or to nucleocapsid provides strong protection against infection with this virus for up to six months.